2025-06-03-Bernstein-达索系统（DSY）_达索系统_下一次CMD预计会有什么内容_19页_994kb

Analysis and Summary: Dassault Systèmes (DSY) Upcoming CMD and Financial Outlook

Overview of Upcoming CMD

• Dassault Systèmes (DSY) is set to hold its CMD on June 6, 2025.
• No significant rally is anticipated on that day; the company is expected to focus on reassuring investors rather than surprising them.
• Key topics for discussion include financial communication, performance vs. ambitions, and clarity on growth drivers.

Financial Performance and Outlook

• Current price target is EUR 48.00, with upside potential of 49% from the current price.
• Revenue growth guidance for FY2025 remains cautious, with software growth expected between +3% and +7% in Q2, despite prior miss in 1Q2025 with +5% growth.
• FY2025 software revenue guidance of +6-8% CCS aligns with recent performance.
• EPS target for FY2028 is €2.00, with estimates projecting sales around €9.5bn, though figures suggest potential delays in achieving these goals.
• Full-year dependency on Q3-Q4 performance is high, tied to commercial opportunities and macroeconomic factors.

Key Concerns and Areas of Focus

• Revenue Performance: DSY's revenue growth has lagged initial 2023 ambitions, with global GDP and sector-specific issues (e.g., automotive and Medidata) weighing on results. Visibility on FY2025 and FY2028 targets remains uncertain due to factors like US tariffs and CROs' economic climate.
• Medidata Challenges: Medidata's sales growth has been weak (+13% in 1Q2025), falling short of its +13-15% CAGR forecasts. Key issues include headwinds from federal budget cuts, slow clinical trial launches, and lack of confidence in its turnaround plans.
• AI Integration: DSY's AI-powered solutions hold medium-to-long-term revenue potential, but monetization remains a key question. Pricing models (e.g., seat-based, consumption-based) and adoption within the installed base need more transparency.
• Subscription Transition: Progress in shifting to subscription revenue underestimates the model's impact. Upfront contract revenue dilutes visibility, and more detailed KPIs on customer migration and financial metrics are requested.
• Manufacturing and China Exposure: High-revenue sectors like automotive are sensitive to macroeconomic shifts. China's volatility (not back-end loaded historically) requires clearer growth projections in APAC regions.

Investment Implications

• Rating: Outperform
• Bernstein recommends a EUR 48 price target, driven by strong fundamentals, despite short-term risks. Upside potential exists based on current multiples and sales growth.
• Strong fundamentals support a positive view, but uncertainties in FY2025 guidance and Medidata require close monitoring.

Management Questions for Investors

• Clarify subscription model transition timelines and revenue impact.
• Specify AI solutions' pricing and revenue ambitions.
• Detail customer migration progress from older software versions.
• Elaborate on Medidata's growth outlook and KPIs.
• Improve financial KPI transparency for cash generation, ACV, and backlog metrics.
• Reaffirm organic revenue growth and margin targets.

In summary, while DSY's fundamentals are robust, its achievement of long-term goals depends on addressing current revenue gaps, improving investor visibility on key KPIs, and managing execution risks in drivers like AI monetization and Medidata performance.